Retatrutide is an investigational peptide compound being studied for its ability to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—which are involved in regulating appetite, energy balance, and glucose metabolism.
Developed for research purposes, retatrutide is designed to help scientists explore how multi-pathway receptor activation may influence metabolic processes. It is not FDA-approved, not intended for human consumption, and is provided strictly for laboratory and scientific research use.








Reviews
There are no reviews yet.